Ultralife Corporation (NASDAQ: ULBI) reported revenue of $39.8
million for its first quarter ended March 29, 2009, a decrease of $9.8
million, or 20%, from the $49.6 million in revenue reported for the
comparable quarter of 2008. The company reported an operating loss of
$2.3 million in the first quarter of 2009, compared with operating
income of $2.4 million in the same period a year ago.
The $9.8 million decrease in revenue resulted primarily from lower
shipments of advanced communications systems, as orders received in the
latter part of 2007 were fulfilled during 2008. Partially offsetting
this was a near doubling of rechargeable product revenue as demand for
rechargeable batteries and chargers rose. Consolidated gross margin for
the first quarter was 20%, compared with 22% in the same quarter a year
ago.
Operating expenses for the first quarter of 2009 totaled $10.0 million
compared to $8.5 million a year ago. The $1.5 million increase in
operating expenses was attributable to increases in product development
costs, higher selling and marketing expenses related to the development
of the standby power business, and generally higher administrative
costs. The net loss for the first quarter of 2009 was $2.5 million, or
$0.15 per share, compared with net income of $2.4 million, or $0.14 per
share, for the same quarter in 2008.
During the first quarter of 2009, borrowings under the company’s
revolving credit facility increased $16.6 million. This resulted
primarily from the acquisition of assets associated with the AMTI brand
in March 2009 that required $5.7 million in cash, the repurchase of
approximately 416,000 shares of the company’s common stock for $3.3
million under the company’s share repurchase program, and the
prepositioning of inventory for an anticipated order.
“Our fiscal year 2009 has started more slowly than we had planned,” said
John D. Kavazanjian, president and chief executive officer. “First, the
release of government/defense orders is taking longer than anticipated.
Although funding for the related programs is in place, there have been
government delays in finalizing the proper contract vehicles. However,
in order to be responsive to anticipated customer needs, our inventory
levels rose during the quarter to put us in a delivery-ready mode.
Second, severe price competition by component suppliers has been putting
pressure on the margins in our standby power business. To combat these
short-term pricing dynamics, we are intensifying our efforts to market
our system solutions, which bundle services and products, to customers
and prospects. We believe that our value-added solutions approach,
combined with our engineering and services capabilities and growing
national footprint, creates a compelling advantage that will support
long-term growth in the standby power market.”
Kavazanjian added, “Although we still expect orders for our advanced
communications systems and rechargeable batteries and charging systems
to be released against government/defense programs in 2009, our
assumption is that administrative delays will cause implementation of
these programs to be one quarter later than previously anticipated. In
other areas of our business, our outlook for growth remains unchanged.”
Outlook
As a result of the delays in government/defense programs, management has
lowered its revenue guidance for 2009 from $250 million to approximately
$230 million and reduced its operating income estimate from
approximately $20 million to approximately $13 million.
About Ultralife Corporation
Ultralife Corporation, which began as a battery company, now serves its
markets with products and services ranging from portable and standby
power solutions to communications and electronics systems. Through its
engineering and collaborative approach to problem solving, Ultralife
serves government, defense and commercial customers across the globe.
Ultralife’s family of brands includes: Ultralife Batteries, Stationary
Power Services, RPS Power Systems, ABLE, McDowell Research, RedBlack
Communications and AMTI. Ultralife’s operations are in North America,
Europe and Asia. For more information, visit www.ultralifecorp.com.
This press release may contain forward-looking statements based on
current expectations that involve a number of risks and uncertainties.
The potential risks and uncertainties that could cause actual results to
differ materially include: worsening global economic conditions,
increased competitive environment and pricing pressures, disruptions
related to restructuring actions and delays. The Company cautions
investors not to place undue reliance on forward-looking statements,
which reflect the Company’s analysis only as of today’s date. The
Company undertakes no obligation to publicly update forward-looking
statements to reflect subsequent events or circumstances. Further
information on these factors and other factors that could affect
Ultralife's financial results is included in Ultralife's Securities and
Exchange Commission (SEC) filings, including the latest Annual Report on
Form 10-K.
Conference Call Information
Investors are invited to listen to a live webcast of the conference call
at 10:00 a.m. ET on April 30, 2009 at http://investor.ultralifecorp.com.
To listen to the live call, please go to the web site at least fifteen
minutes early to download and install any necessary audio software. For
those who cannot listen to the live broadcast, a replay of the webcast
will be available shortly after the call at the same location for 90
days. Investors may also listen to a telephone replay of the conference
call by dialing 800-915-4836, Reservation 2784675, during the period
starting at 1:00 p.m. ET April 30 and ending at 1:00 p.m. ET May 7, 2009.
|
|
|
|
|
|
|
|
|
|
ULTRALIFE CORPORATION
|
|
|
CONSOLIDATED STATEMENTS OF OPERATIONS
|
|
|
(In Thousands, Except Per Share Amounts)
|
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three-Month Periods Ended
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 29,
|
|
March 29,
|
|
|
|
|
|
|
2009
|
|
|
|
2008
|
|
|
|
|
|
|
|
|
|
|
|
Revenues:
|
|
|
|
|
|
|
|
Non-rechargeable products
|
|
|
$
|
15,572
|
|
|
$
|
14,616
|
|
|
|
Rechargeable products
|
|
|
|
13,854
|
|
|
|
6,738
|
|
|
|
Communications systems
|
|
|
|
4,236
|
|
|
|
24,054
|
|
|
|
Design and installation services
|
|
|
|
6,141
|
|
|
|
4,179
|
|
|
|
Total revenues
|
|
|
|
39,803
|
|
|
|
49,587
|
|
|
|
|
|
|
|
|
|
|
|
Cost of products sold:
|
|
|
|
|
|
|
|
Non-rechargeable products
|
|
|
|
12,750
|
|
|
|
11,632
|
|
|
|
Rechargeable products
|
|
|
|
10,416
|
|
|
|
5,537
|
|
|
|
Communications systems
|
|
|
|
3,196
|
|
|
|
17,861
|
|
|
|
Design and installation services
|
|
|
|
5,660
|
|
|
|
3,682
|
|
|
|
Total cost of products sold
|
|
|
|
32,022
|
|
|
|
38,712
|
|
|
|
|
|
|
|
|
|
|
|
Gross margin
|
|
|
|
7,781
|
|
|
|
10,875
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses:
|
|
|
|
|
|
|
|
Research and development
|
|
|
|
1,980
|
|
|
|
1,609
|
|
|
|
Selling, general, and administrative
|
|
|
|
8,058
|
|
|
|
6,903
|
|
|
|
Total operating expenses
|
|
|
|
10,038
|
|
|
|
8,512
|
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss)
|
|
|
|
(2,257
|
)
|
|
|
2,363
|
|
|
|
|
|
|
|
|
|
|
|
Other income (expense):
|
|
|
|
|
|
|
|
Interest income
|
|
|
|
3
|
|
|
|
11
|
|
|
|
Interest expense
|
|
|
|
(182
|
)
|
|
|
(329
|
)
|
|
|
Gain on insurance settlement
|
|
|
|
-
|
|
|
|
39
|
|
|
|
Gain on debt conversion
|
|
|
|
-
|
|
|
|
313
|
|
|
|
Miscellaneous
|
|
|
|
11
|
|
|
|
69
|
|
|
|
Income (loss) before income taxes
|
|
|
|
(2,425
|
)
|
|
|
2,466
|
|
|
|
|
|
|
|
|
|
|
|
Income tax provision-current
|
|
|
|
2
|
|
|
|
54
|
|
|
|
Income tax provision (benefit)-deferred
|
|
|
|
89
|
|
|
|
(9
|
)
|
|
|
Total income taxes
|
|
|
|
91
|
|
|
|
45
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
|
|
(2,516
|
)
|
|
|
2,421
|
|
|
|
|
|
|
|
|
|
|
|
Net loss attributable to noncontrolling interest
|
|
|
|
4
|
|
|
|
13
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) attributable to Ultralife
|
|
|
$
|
(2,512
|
)
|
|
$
|
2,434
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) attributable to Ultralife common shareholders -
basic
|
|
|
$
|
(0.15
|
)
|
|
$
|
0.14
|
|
|
|
Net income (loss) attributable to Ultralife common shareholders -
diluted
|
|
|
$
|
(0.15
|
)
|
|
$
|
0.14
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding - basic
|
|
|
|
17,115
|
|
|
|
17,027
|
|
|
|
Weighted average shares outstanding - diluted
|
|
|
|
17,115
|
|
|
|
17,441
|
|
|
ULTRALIFE CORPORATION
|
|
CONSOLIDATED BALANCE SHEETS
|
|
(In Thousands, Except Per Share Amounts)
|
|
(unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
March 29,
|
|
December 31,
|
|
ASSETS
|
|
|
|
2009
|
|
|
|
2008
|
|
|
|
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
|
Cash and investments
|
|
|
$
|
943
|
|
|
$
|
1,878
|
|
|
Trade accounts receivable, net
|
|
|
|
32,040
|
|
|
|
30,588
|
|
|
Inventories
|
|
|
|
48,076
|
|
|
|
40,465
|
|
|
Prepaid expenses and other current assets
|
|
|
|
2,155
|
|
|
|
2,242
|
|
|
Total current assets
|
|
|
|
83,214
|
|
|
|
75,173
|
|
|
|
|
|
|
|
|
|
Property and equipment
|
|
|
|
18,095
|
|
|
|
18,465
|
|
|
|
|
|
|
|
|
|
Other assets
|
|
|
|
|
|
|
Goodwill, intangible and other assets
|
|
|
|
39,881
|
|
|
|
35,949
|
|
|
|
|
|
|
|
|
|
Total Assets
|
|
|
$
|
141,190
|
|
|
$
|
129,587
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS' EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
Short-term debt and current portion of long-term debt
|
|
|
$
|
17,576
|
|
|
$
|
1,425
|
|
|
Accounts payable
|
|
|
|
20,453
|
|
|
|
20,255
|
|
|
Other current liabilities
|
|
|
|
11,398
|
|
|
|
10,556
|
|
|
Total current liabilities
|
|
|
|
49,427
|
|
|
|
32,236
|
|
|
|
|
|
|
|
|
|
Long-term liabilities:
|
|
|
|
|
|
|
Long-term debt and capital lease obligations
|
|
|
|
4,029
|
|
|
|
4,670
|
|
|
Other long-term liabilities
|
|
|
|
4,669
|
|
|
|
4,528
|
|
|
Total long-term liabilities
|
|
|
|
8,698
|
|
|
|
9,198
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders' equity:
|
|
|
|
|
|
|
Ultralife equity:
|
|
|
|
|
|
|
Common stock, par value $0.10 per share
|
|
|
|
1,821
|
|
|
|
1,815
|
|
|
Capital in excess of par value
|
|
|
|
168,031
|
|
|
|
167,259
|
|
|
Accumulated other comprehensive income (loss)
|
|
|
|
(1,977
|
)
|
|
|
(1,930
|
)
|
|
Accumulated deficit
|
|
|
|
(77,292
|
)
|
|
|
(74,780
|
)
|
|
|
|
|
|
90,583
|
|
|
|
92,364
|
|
|
Less -- Treasury stock, at cost
|
|
|
|
7,558
|
|
|
|
4,232
|
|
|
Total Ultralife equity
|
|
|
|
83,025
|
|
|
|
88,132
|
|
|
Noncontrolling interest
|
|
|
|
40
|
|
|
|
21
|
|
|
Total shareholders' equity
|
|
|
|
83,065
|
|
|
|
88,153
|
|
|
|
|
|
|
|
|
|
Total Liabilities and Shareholders' Equity
|
|
|
$
|
141,190
|
|
|
$
|
129,587
|
|

Ultralife Corporation
Robert
W. Fishback, 315-332-7100
bfishback@ulbi.com
or
Investor
Relations:
Lippert/Heilshorn &
Associates, Inc.
Jody Burfening, 212-838-3777
jburfening@lhai.com